XRN1 encodes an abundant cytoplasmic exoribonuclease, Xrn1p, responsible for mRNA turnover in yeast. A screen for bypass suppressors of the inviability of xrn1 ski2 double mutants identified dominant alleles of RAT1, encoding an exoribonuclease homologous with Xrn1p. These RAT1 alleles restored XRN1-like functions, including cytoplasmic RNA turnover, wild-type sensitivity to the microtubule-destabilizing drug benomyl, and sporulation. The mutations were localized to a region of the RAT1 gene encoding a putative bipartite nuclear localization sequence (NLS). Fusions to green fluorescent protein were used to demonstrate that wild-type Rat1p is localized to the nucleus and that the mutant alleles result in mislocalization of Rat1p to the cytoplasm. Conversely, targeting Xrn1p to the nucleus by the addition of the simian virus 40 large-T-antigen NLS resulted in complementation of the temperature sensitivity of a rat1-1 strain. These results indicate that Xrn1p and Rat1p are functionally interchangeable exoribonucleases that function in and are restricted to the cytoplasm and nucleus, respectively. It is likely that the higher eukaryotic homologs of these proteins will function similarly in the cytoplasm and nucleus.
In the yeast Saccharomyces cerevisiae, the 5Ј33Ј exoribonuclease I, Xrn1p, encoded by the XRN1 gene, is the primary cytoplasmic RNase responsible for mRNA degradation (30) . Xrn1p acts at the last step in mRNA turnover, after deadenylation and decapping (reviewed in reference 4). Consequently, xrn1 mutants accumulate many different mRNA species as deadenylated and decapped RNAs, displaying the highest mRNA levels relative to the wild type for short-lived transcripts (9, 18) . Mutants deficient in XRN1 also accumulate decapped intermediates of the deadenylation-independent nonsense-mediated decay pathway (34) . Significantly, the decapped RNAs that accumulate in xrn1 mutants persist in polysomes (6, 15) , suggesting that in the absence of Xrn1p exonuclease, transcripts targeted for degradation by decapping continue to be translated. Xrn1p degrades other classes of RNAs as well, including internal transcribed spacer 1 (ITS1) (39) , a byproduct of rRNA processing. Thus, Xrn1p has broad substrate specificity.
Xrn1p was first purified from yeast extracts in a search for RNA turnover factors based on its exoribonuclease activity (38) . Subsequently, the enzyme has been purified from biochemical fractionations as a DNA strand exchange activity referred to as Sep1p (13, 28) and as a DNA G4 tetraplexspecific nuclease referred to as Kem1p (32) . The gene has also been identified in various genetic screens. It was identified as KEM1, mutation of which enhances the karyogamy defect in kar1 mutants (26) . kem1 mutants were shown to be hypersensitive to benomyl, a microtubule-destabilizing drug, and it has subsequently been suggested that Xrn1p may physically interact with microtubules (19) . XRN1 was also identified as RAR5 in a screen for mutants that destabilized plasmids containing defective ARS elements (27) . In addition, xrn1 mutants display a superkiller phenotype, and the superkiller mutation ski1-1 is most probably allelic to XRN1 (21) . Although the myriad putative activities of Xrn1p would suggest a multifunctional enzyme that acts both in the nucleus and in the cytoplasm, these results can also be rationalized by a model in which gene regulation is globally altered by an inability to remove transcripts in a timely fashion from the translation machinery in the cytoplasm. This model is supported by the finding that Xrn1p is a cytoplasmic protein (17) .
The RAT1 gene encodes a second 5Ј33Ј exoribonuclease of S. cerevisiae (24) , which shares considerable homology with Xrn1p (2) . The RAT1 gene product, also identified as exonuclease II (Exo II) (40) , will be referred to as Rat1p for clarity. Biochemically the two enzymes are very similar. Both require a 5Ј-terminal phosphate for activity and degrade singlestranded RNA to yield mononucleotides (36, 40) . However, in vivo the enzymes have quite different roles: RAT1 is essential (2, 12, 24) and rat1-1 mutants are not rescued by high-copynumber expression of XRN1, whereas XRN1 is nonessential, but high-copy-number expression of RAT1 partially restores the growth and RNA turnover defects of xrn1 mutants (36) . The rat1-1 allele was identified in a screen for factors involved in the export of poly(A) mRNA from the nucleus (2), although this phenotype was not observed for another allele of RAT1 (2) . The gene was also identified as TAP1, mutations in which activated polymerase III (Pol III) transcription of a mutated tRNA gene (1); however, this activation was dependent on the sequence context of the tRNA gene (11) , suggesting that RAT1 was not a general factor in Pol III transcription. RAT1 was identified as HKE1 in a reverse genetic approach based on the sequence of the purified exonuclease (24) . Most recently, the rsf11 allele of RAT1 was identified as synthetically lethal with a deletion of SWI4 (44) . The double mutant could be rescued by high-copy-number expression of CLN1, CLN2, or RME1; however, rsf11-specific suppressors were not reported. Although these results suggest a nuclear role for RAT1, this has not been clearly demonstrated. In addition, it has been suggested that the residual and presumably cytoplasmic 5Ј exoribonuclease active on decapped mRNAs observed in cells from which xrn1 has been deleted may be due to RAT1 (33) .
Xrn1p and Rat1p homologs are found in other eukaryotes as well. Based on sequence alignments, the various homologs can be divided into Xrn1p-like and Rat1p-like proteins, suggesting that the two protein subfamilies have separate and conserved functions throughout eukaryotes. Exo II from Schizosaccharomyces pombe and EXOp from the mouse are homologs of Xrn1p and have been shown biochemically to be exonucleases (23, 41a) . Dhp1 from S. pombe (41) and Dhm1 from the mouse (37) are homologs of Rat1p. In addition, a human homolog of RAT1 has been cloned, and the expressed protein contains exonuclease activity (13a). Comparison of Xrn1p and Rat1p protein sequences with the complete sequence databases from the prokaryotes Haemophilus influenzae and Methanococcus jannaschii (by using the FASTA alignment algorithm, Baylor College of Medicine) revealed no significant similarity to prokaryotic gene products, suggesting that the Xrn1p protein family is unique to eukaryotes. This specificity to eukaryotic organisms may reflect basic differences in pathways of mRNA turnover between prokaryotic and eukaryotic cells. mRNA turnover in prokaryotes generally requires the activities of endonucleases and 3Ј35Ј exoribonucleases (5) . In contrast, mRNA degradation in yeast generally requires 5Ј33Ј exoribonucleases (4, 9, 10) . Intermediates for mRNA decay in higher eukaryotes have generally eluded identification, precluding the delineation of a general decay pathway. However, the presence of a functional Xrn1p homolog in the mouse suggests that the 5Ј degradation pathway is used.
A screen for mutations synthetically lethal with an xrn1 mutation previously identified mutations in the antiviral genes SKI2, a putative RNA helicase, and SKI3 (21) and in the essential gene NMD3 (17a). The synthetic lethality with mutations in the SKI2 and SKI3 genes was independent of L-A, the major double-stranded RNA virus of yeast, and suggested a general role for SKI2 and SKI3 in control of translation of deadenylated transcripts (21) . Ski2p may confer specificity for translation of poly(A)-containing mRNAs (21, 35, 45) or may act in a 3Ј RNA degradation pathway. This report presents the results of a screen for mutations that restore viability to a strain with deletions of XRN1 and SKI2. It was envisioned that this screen could reveal at least two classes of mutations: those that activated additional transacting RNA turnover or translational control factors and those in critical Xrn1p or Ski2p RNA substrates that altered the RNA's susceptibility to alternative degradation pathways or its ability to be translated. However, the bypass suppressors identified in this screen were exclusively dominant alleles of RAT1 that resulted in mislocalization of Rat1p to the cytoplasm. In separate experiments, targeting Xrn1p to the nucleus rescued rat1-1 mutants. These results provide compelling evidence that Rat1p and Xrn1p are functionally equivalent proteins localized to the nucleus and cytoplasm, respectively, and that the essential role of RAT1 is in the nucleus. It is likely that the two subfamilies of Xrn1p homologs found throughout eukaryotes exist for separate cytoplasmic and nuclear functions.
MATERIALS AND METHODS
Strains and genetic methods. Yeast strains used in this study are listed in Table 1 . Rich yeast extract-peptone-dextrose (YPD) medium, 5-fluoroorotic acid (5FOA), dropout media, and standard yeast manipulations were as described elsewhere (22) . Low-adenine plates for colony-sectoring assay were prepared as described elsewhere (29) . Yeast transformations were carried out as previously described (14) , except that cells to be transformed were grown as light lawns on plates. Benomyl sensitivity was assayed as described previously (26) by using YPD plates containing 15 g of benomyl/ml.
Screen for bypass suppressors. Three independent mutageneses were performed. Typically, an overnight culture of strain AJY415 was grown in YPD medium. The cells were collected by centrifugation, washed with sterile water, and resuspended in water at a density of 6 ϫ 10 7 /ml. The cells were irradiated with UV light to give 25% survival and plated at a density of 2 ϫ 10 5 surviving cells/plate on YPD plates, which were then incubated at 37°C. Fifty-seven potential temperature-resistant colonies were picked, and 21 of these were rescored as temperature resistant and resistant to 5FOA, indicating that suppression was not dependent on the plasmid-borne xrn1-10 ts allele. PCR analysis of genomic DNA prepared from cells grown on 5FOA confirmed that none of the mutants retained an intact XRN1 coding sequence (data not shown), indicating that the suppressors did not arise from conversion of the genomic xrn1⌬ allele to the wild type. All mutants were mated with strain RKY2053 to test for dominance. In all cases, the diploids gave rise to sectored colonies on YPD plates, indicating loss of the ADE3 plasmid and demonstrating that all the suppressor mutations were dominant. The diploids from these crosses were sporulated, and the resulting tetrads were dissected. Fourteen of the mutants yielded 2:2 segregation for sectored/solid red, indicating that the suppressors resulted from mutations at single loci. Two others gave aberrant ade2-dependent color development and were not analyzed further. Five diploids either failed to sporulate or yielded a high frequency of inviable spores.
Spore clones of the appropriate mating type from the 14 crosses with RKY2053 that yielded single loci were mated with strain DAT1-17, bearing the temperature sensitivity rat1-1 allele (2). Diploids were sporulated, and tetrads were dissected. The unmarked xrn1⌬ allele was scored by PCR. In all crosses, the suppressing mutation, scored as viable xrn1⌬ ski2::LEU2 spore clones, segregated away from the rat1-1 allele, scored by temperature sensitivity, indicating that the suppressing mutations were tightly linked to rat1-1.
Allele rescue and mapping. Plasmid pAJ202, bearing URA3, was digested with XbaI and SstI restriction enzymes to remove sequences from Ϫ134 to 2785 of RAT1. The vector fragment was then transformed into 12 of the original suppressor strains, 9 of which had been identified as RAT1 alleles (see above) and three of which had not been determined to be alleles of RAT1 due to poor sporulation after mating with RKY2053. DNA was prepared from the Ura ϩ colonies and was transformed into Escherichia coli. Plasmids propagated in E. coli were then transformed into yeast strain AJY354 to test for suppression of xrn1 ski2 by a colony-sectoring assay. All rescued plasmids allowed sectoring on Ura dropout low-adenine plates, whereas the wild-type RAT1 allele did not, confirming that all the rescued suppressing mutations were within, or immediately 5Ј of, the RAT1 coding sequence. From these analyses, 17 of the original suppressor mutations were identified as RAT1 mutations.
To localize the mutations in the gap-rescued RAT1 alleles, plasmid pAJ203 was digested with XbaI and SalI, SalI and SacII, SacII and NcoI, and NcoI and SstI to yield gaps in the RAT1 sequence from nucleotide Ϫ134 to 85, 85 to 512, 512 to 1992, and 1992 to 2785, respectively. The gapped plasmids were then transformed into the 12 Ura ϩ isolates in the AJY354 background, described above, and Leu ϩ transformants were scored for growth on 5FOA, indicative of the conversion of the transforming vector by the RAT1 dominant alleles, allowing loss of the URA3 vector. In all cases, the highest frequency of 5FOA resistance resulted from plasmids gapped by SacII and NcoI. The RAT1 alleles in pAJ202 were sequenced from nucleotide 512 to 1992 by dye-terminated dideoxy sequencing (Molecular Biology Core Facility, University of Texas at Austin), and all contained single nucleotide changes. PCR was used to amplify the RAT1 locus from the remaining five RAT1 mutants that had not been rescued to plasmids and from one mutant which had not been characterized previously due to poor spore viability. Oligonucleotides AJO131 (5Ј-TCTTGCCCAGTAAAAGCTCTC ATG) and AJO150 (5Ј-CGCTATGCCTTGCCAGG) were used to amplify RAT1 from nucleotide 476 to 2208. The amplified products were reamplified with oligonucleotides AJO132 (5Ј-GGGCTATCGACGATTGGG) and AJO150. The products were gel purified, and the region from nucleotide 1450 to 1800 was sequenced by dye-terminated sequencing (BioTech Core, Palo Alto, Calif.).
Plasmids. See Table 2 for a compilation of plasmids used in this work. All nucleotide numbering is relative to the translation start, defined as ϩ1 of the respective gene. pAJ76 is a 2m-based ADE3 XRN1 plasmid. A 5.8-kb SKI2-containing XbaI fragment from the SKI2 genomic clone, p2-26/8-3, was blunt ended with T4 DNA polymerase and ligated into the SmaI site of pAJ60. pAJ202 was constructed by replacing the 448-bp PvuII fragment of pRS416 with the RAT1-containing fragment of pRAT1-18, which had been digested with EcoRI and filled in with Klenow fragment. pAJ96 was made by replacing the 445-bp PvuII fragment of pRS315 with the ϳ9-kbp RAT1-containing AatII fragment of pRAT1-10, which had been blunt ended with T4 DNA polymerase. pAJ203 was derived from pAJ96 by removing a 2-kbp XbaI-to-NheI fragment upstream of and including the XbaI site at position Ϫ1542 of RAT1. pAJ96 was partially digested with XbaI and fully digested with NheI. The appropriate fragment was gel isolated and religated, yielding a unique XbaI site at position Ϫ134 of RAT1. pAJ240 and pAJ241 contain the K537E and L520P RAT1 mutants subcloned into pAJ203.
NLS and green fluorescent protein (GFP) constructs. pAJ228 was derived from pAJ203 and contains a mutated RAT1 gene that expresses Rat1p from which the nuclear localization signal (NLS) has been deleted. Oligonucleotide primers AJO131 (5Ј-CGATCACTCCAGGCACCC) and AJO140 (5Ј-GATTCC GCTTTCTCTGTATTTATTATTTTCTGTTTC), reading antiparallel and encoding the NLS deletion, were used to amplify RAT1 from nucleotide 476 to 1628 and to delete the nucleotide sequence of RAT1 from 1546 to 1611, AAGAAACA CCGTCTTGAAAAGGATAATGAAGAGGAAGAAATTGCTAAGGATAG CAAAAAAGTTAAG, encoding KKHRLEKDNEEEEIAKDSKKVK. Separately, oligonucleotides AJO139 (5Ј-ACAGAGAAAGCGGAATC) and AJO150 were used to amplify a fragment of RAT1 from nucleotide 1612 to 2208. The two products, which overlapped by 17 nucleotides, were mixed and reamplified with outside primers only. The resulting product was digested with ScaI and NcoI to replace the corresponding fragment in pAJ203. pAJ229, prepared similarly, expresses Rat1p in which the three lysines of the second basic cluster of the NLS have been changed to alanines, changing the sequence KKVK (amino acids 534 to 537) to AAVA. Oligonucleotide primer AJO139 and the mutagenic primer AJO141 (GATTCCGCTTTCTCTGTCGCAACTGCTGCGCTATCCTTAGC AATTTC), reading antiparallel, were used to amplify RAT1 from nucleotide 476 to 1628. Separately, oligonucleotides AJO139 and AJO150 were used to amplify a fragment of RAT1 from nucleotide 1612 to 2208. The two products, which overlapped by 17 nucleotides, were mixed and reamplified with outside primers only. The resulting product was digested with ScaI and NcoI to replace the corresponding fragment in pAJ203.
RAT1-GFP gene fusions were prepared by amplifying the m2 mutant GFP with enhanced fluorescence from plasmid pTD150 by using the oligonucleotide primers AJO143 (5Ј-CGCTCCGGAGAGCTCATGAGTAAAGGAGAA) and AJO142 (5Ј-CGGGCTAGCTCCGGATTATTTGTATAGTTCAT). The resulting fragment, which contained the GFP gene flanked by BspEI sites, was cleaved with BspEI and ligated into the BspEI site at nucleotide 2926 of RAT1 in plasmids pAJ202, pAJ206, pAJ209, pAJ228, and pAJ229 to yield plasmids pAJ226, pAJ230, pAJ231, pAJ232, and pAJ233, respectively. The correct orientation of the GFP insert in these plasmids was determined by restriction digests. The remaining RAT1 mutants, ⌬492-529, H518Y, and K535N, were gap rescued by using plasmids pAJ228 and pAJ232 digested with SalI and SstI. The correct mutants were identified by the replacement of the ⌬NLS mutant in pAJ228 and pAJ232.
pAJ237 contained the XRN1-GFP fusion containing the simian virus 40 (SV40) large-T-antigen NLS. It was made by amplifying m2 mutant GFP from plasmid pTD150 with the oligonucleotide primers AJO158 (5Ј-CTGGGCTAGC CCAAAGAAGAAGAGAAAGGTCGACATGAGTAAAGGAGAAG) and AJO142, described above (nucleotides encoding the NLS PKKKRKV are underlined). The resulting DNA fragment was digested with NheI and ligated into NheI-digested pRDK318. pRDK318 is a URA3 2m shuttle vector derived from pRDK242 containing the XRN1 gene in which an oligonucleotide encoding the hemagglutinin (HA) epitope and introducing a unique NheI site was inserted into the EcoRI site at nucleotide 3894 of XRN1. The construction of pRDK318 will be described elsewhere. Xrn1-HA expressed from pRDK318 is indistinguishable from the wild type in vivo. The XRN1 mutant, xrn1(E178G), was made by in vitro random PCR mutagenesis of XRN1 on a plasmid and was identified by its lack of complementation of xrn1 ski2 lethality. A more extensive description of this allele will be presented elsewhere. The xrn1(E178G) mutant was subcloned on a 4.5-kb SstI and HindIII restriction fragment into pAJ237 to make an xrn1(E178G) SV40 NLS-GFP fusion.
Northern blot analysis. Ten-milliliter cultures were grown in dropout medium to a density of approximately 10 7 cells/ml. RNA was prepared, and 10 g of total RNA was fractionated by electrophoresis through formaldehyde-agarose gels (1.25% agarose) as described elsewhere (22) . RNA was transferred to a ZetaProbe membrane (Bio-Rad) by vacuum transfer in 10ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate). Radiolabeled probes for CYH2 and MFA2 were prepared by random priming (High Prime; Boehringer Mannheim), by using as templates a CYH2 fragment (nucleotide 34 to 934) generated by PCR amplification of the genomic CYH2 locus with the oligonucleotides AJO119 (5Ј-AGAGGTCACGTCTCAGG) and AJO120 (5Ј-ACAACACCACCAGCA GC) and the MFA2-containing EcoRI fragment from pRP590. A radiolabeled probe specific for ITS1 was prepared by phosphorylating oligonucleotide AJO130 (5Ј-TCTTGCCCAGTAAAAGCTCTCATG). Blotting was carried out according to the manufacturer's instructions for ZetaProbe (Bio-Rad). Blots were imaged and quantitated on a Molecular Dynamics PhosphorImager.
Microscopy. Fresh overnight cultures of cells grown in appropriate selective media were diluted to approximately 10 7 cells/ml and cultured for 4 h, after which 4Ј,6-diamidino-2-phenylindole (DAPI) was added to a final concentration of 0.5 g/ml. The cultures were grown for an additional 30 min and then photographed with a Zeiss Axiophot microscope fitted with a 100ϫ objective and using Kodak T-Max 400 film. All cultures in the rat1-1 background (DAt1-17) were grown at 26°C.
Western blotting. Anti-Rat1p antiserum was a generous gift of Mark MacCammon and was affinity purified against a TrpE::Rat1 fusion protein expressed in E. coli from plasmid pTT3 as described previously (1) . Yeast total soluble protein extracts were prepared and protein concentrations were determined as previously described (20) . Proteins were separated on a sodium dodecyl sulfate-8% polyacrylamide gel and transferred to nitrocellulose membranes, and 
RESULTS
A screen of UV-mutagenized cells was carried out to identify mutations that rescued the inviability of xrn1 ski2 mutants. Twenty-one such bypass suppressors were identified at a frequency of approximately 5 ϫ 10 Ϫ7 . All were dominant mutations, and 18 were characterized by linkage analysis or direct sequencing of genomic PCR products as alleles of RAT1, encoding an exoribonuclease that shows considerable homology with Xrn1p. The remaining three mutants were not further characterized due to aberrant tetrad analysis. Since RAT1 is a high-copy-number suppressor of xrn1 (36), a potentially trivial explanation for bypass suppression by the RAT1 dominant alleles was that they allowed overexpression of RAT1. However, Western blot analysis showed that the dominant alleles did not significantly overexpress Rat1p (Fig. 1 and data not  shown) .
The 18 RAT1 mutants comprised five distinct mutations: H518Y, L520P, K535N, K537E, and ⌬492-529. The H518Y mutation, in which histidine at position 518 is changed to tyrosine, was represented by one isolate and resulted from a C-to-T transition at nucleotide 1552. L520P was represented by three isolates and resulted from a T-to-C transition mutation of nucleotide 1559. The K535N mutant was found once and resulted from an A-to-T transversion mutation at nucleotide 1605. Nine isolates of K537E were identified, and all contained an A-to-G transition mutation of nucleotide 1609. Lastly, the ⌬492-529 mutation was a small in-frame deletion of 114 nucleotides between and including one of two repeated dodecamer DNA sequences, AGGAAGAAATTG, which occur at nucleotides 1463 to 1474 and 1577 to 1588. The abundant mutants, K537E and L520P, were most extensively characterized. When reintroduced on single-copy plasmids into an xrn1 ski2 double mutant, the L520P and K537E RAT1 mutants, but not the wild type, allowed the loss of an XRN1-bearing plasmid (Fig. 2) . However, the two mutations differed in their abilities to suppress the growth defect of the double mutant; the L520P mutation showed weaker suppression than the K537E mutation. To confirm that these mutations alone were sufficient for the dominant phenotype, the sequenced regions were subcloned into an otherwise wild-type RAT1 allele, where they again conferred a dominant phenotype (data not shown). In this plasmid shuffle assay, the mutations K535N, ⌬492-529, and H518Y showed suppression similar to that of the K537E mutation (data not shown).
To test the specificity of suppression, plasmids bearing the dominant RAT1 mutations, K537E and L520P, were transformed into xrn1 ski3 and xrn1 nmd3-1 double mutants that also contained a plasmid bearing XRN1 and URA3 genes. The dominant alleles allowed loss of the XRN1 URA3 plasmid from these cells, demonstrating suppression (data not shown). These results and the complementation of xrn1-specific in vivo defects (see below) show that the RAT1 alleles are specific for the suppression of xrn1.
All five suppressor mutations fell within a discrete region of the RAT1 gene predicted to be hydrophilic and encoding a short polypeptide loop not found in the XRN1 homologs (Fig.  3a) . Examination of the sequence surrounding the four RAT1 dominant alleles revealed similarity to the consensus bipartite NLS: two basic residues, a 10-amino-acid spacer of any sequence, followed by a cluster of basic residues in which three of five are basic (Fig. 3b) . The putative RAT1 NLS differs from this consensus in that the spacer is 15 amino acids. The K537E   FIG. 1 . Western blot analysis of Rat1p. Ten micrograms of total soluble protein from the strains indicated was separated on a sodium dodecyl sulfate-8% polyacrylamide gel. Affinity-purified anti-Rat1p polyclonal antiserum was used as the primary antibody. Strains: for the wild type (WT), AJY415; for K537E, AJY880; and for L520P, AJY881.
FIG. 2.
Single-copy vectors containing dominant alleles of RAT1 rescue the inviability of xrn1 ski2 double mutants, but wild-type RAT1 does not. Strain RDKY2053 (xrn1⌬ ski2-14; pRDK297) was transformed with pAJ203 (WT), pAJ240 (K537E), or pAJ241 (L520P). Transformants were patched onto 5FOA plates and incubated at 30°C for 2 days. Growth indicates viability upon loss of the URA3 XRN1-containing plasmid pRDK297. mutation alters a conserved basic residue, and the ⌬492-529 mutation removes the amino-terminal basic cluster. In addition, the L520P and H518Y mutations alter amino acids of the spacer region, which is not part of the consensus sequence and reportedly can be of any amino acid sequence. Examination of the amino acid sequence of two Rat1p homologs, Dhp1 from S. pombe and Dhm1 from the mouse, revealed that these two proteins also contained putative NLSs, but at a position different from that found in Rat1p (Fig. 3c) . In Dhp1 the sequence KRLKQQEDRRNENYRRR (amino acids 396 to 412) differs slightly from the consensus by having a spacer region of 12 amino acids. Dhm1 protein contains a consensus NLS, KKRKDDEDSFRRRQKEKRK (amino acids 407 to 423), in a position homologous with that of the NLS in Dhp1. The homologous position within Rat1p contains some characteristics of a bipartite NLS, but the spacer region is extremely short, containing only five amino acids. Nevertheless, it is possible that this sequence serves as a weak NLS (see Discussion).
RAT1 dominant alleles restore XRN1-like function. Xrn1p is an abundant cytoplasmic exoribonuclease (30) and is responsible for the majority of the deadenylation-dependent and deadenylation-independent degradation of mRNA species as well as of other RNAs, including ITS1, from rRNA processing (39) . Consequently, RNA degradation was assayed in the RAT1 mutants. The RAT1 dominant alleles significantly reduced the levels of pre-CYH2 relative to the levels observed in the xrn1⌬ mutant (Fig. 4a) . Quantitation of the blot in Fig. 4a indicated that whereas the ratios of pre-CYH2 to CYH2 in xrn1⌬ and the wild type were 0.7 and 0.05, respectively, the ratios in the RAT1 mutants ranged from 0.24 to 0.29. Steadystate levels of MFA2 transcript, which is degraded by a deadenylation-dependent pathway, also were assayed (Fig. 4b) . Again, the RAT1 mutant alleles reduced the steady-state level from that observed in the xrn1⌬ mutant to levels similar to those observed in wild-type cells. Lastly, the RAT1 alleles reduced the levels of ITS1 observed in xrn1⌬ mutants to levels similar to those found in wild-type cells (Fig. 4c) . Quantitation of the blot in Fig. 4c indicated that ITS1 in wild-type cells was present at approximately 2% of the level found in xrn1⌬ mutants. The levels of ITS1 in the RAT1 mutants ranged from 1 to 3% relative to those in the xrn1⌬ mutant. Thus, for three distinct RNA degradation reactions, the RAT1 alleles restored XRN1-like cytoplasmic RNA degradation. Interestingly, the RAT1 alleles were less efficient at deadenylation-independent degradation of pre-CYH2; however, there did not seem to be a correlation between specific alleles and efficiency of the various degradation reactions.
xrn1 mutants are hypersensitive to benomyl (26) , and Xrn1p may interact directly with tubulin (19) . Consequently, the ability of the RAT1 dominant alleles to suppress the benomyl hypersensitivity was tested. The K537E, H518Y, and ⌬492-529 mutants fully suppressed the benomyl hypersensitivity of xrn1⌬, whereas the L520P and K535N mutants did not (Fig. 5) . In addition, the L520P and K535N mutants showed slightly slower growth on YPD (Fig. 5) , and the L520P mutant showed weaker suppression in a plasmid shuffle assay (Fig. 2) . Thus, there may be a correlation between suppression of benomyl hypersensitivity and suppression of the growth defect of xrn1⌬. xrn1 mutants are also defective for sporulation, arresting at pachytene (43) , although the underlying defect causing this arrest has not been defined. The ability of the dominant K537 mutant of RAT1 to suppress the sporulation defect of xrn1 mutants was tested by mating an xrn1 RAT1(K537) double mutant with an xrn1 deletion mutant in the SK-1 strain background, which sporulates with high efficiency. The K537E mutant restored sporulation of a diploid homozygous for xrn1 deletion to the levels observed for an xrn1 heterozygote (Table  3) .
Mutant Rat1p is mislocalized to the cytoplasm. To test if the putative NLS of RAT1, amino acids 516 to 537, is required for protein localization to the nucleus, mutations were introduced into the RAT1 coding sequence that either eliminated the putative NLS, the resultant mutant being identified as the NLS⌬ mutant, or changed the three lysines of the second basic cluster, amino acids 534 to 537, to alanines, the resultant mutant being identified as the KKK3AAA mutant (Fig. 3b) . The   FIG. 4 . Northern blot analyses of pre-CYH2 and CYH2 (a), MFA2 transcript (b), and ITS1 (c). Ten micrograms of total RNA was separated on formaldehydeagarose gels, transferred to nylon membranes, and probed. All cultures were grown at 30°C. The strain for L520P, K537E, K535N, ⌬492-529, and H518Y, was AJY354, with pAJ209, pAJ206, pAJ351, pAJ352, and pAJ353, respectively, replacing pAJ76; strains for XRN1 and xrn1⌬ were RDKY1974 and RDKY1977, respectively.
FIG. 5.
Complementation of xrn1⌬ benomyl hypersensitivity. Three microliters of each culture was spotted onto a YPD plate or a YPD plate supplemented with 15 g of benomyl/ml and allowed to grow for 2 days at 30°C. Strains: WT, RDKY1974; xrn1⌬, RDKY1977; L520P, K537E, K535N, ⌬492-529, and H518Y, RDKY1977 containing pAJ241, pAJ240, pAJ351, pAJ352, and pAJ353, respectively. localization of wild-type and mutant proteins was monitored by the use of GFP fusions to Rat1p and the mutant proteins. The GFP coding sequence was inserted into the BspEI site of RAT1 at nucleotide 2926, deleting the C-terminal 29 amino acids of Rat1p. All RAT1 GFP fusions were expressed on single-copy CEN vectors under the control of the wild-type RAT1 promoter.
The various protein constructs were tested for their abilities to complement the temperature sensitivity of the rat1-1 allele and the inviability of xrn1 ski2, assayed in a colony-sectoring assay. Whereas wild-type RAT1 on a single-copy vector did not complement xrn1 ski2 inviability, the four rat1 mutants, NLS⌬, K537E, L520P, and KKK3AAA, all complemented both the rat1-1 temperature sensitivity and the xrn1 ski2 inviability (Table 4). Identical complementation results were obtained with constructs lacking GFP (Fig. 2 and data not shown) , suggesting that deletion of the C-terminal 29 amino acids and the addition of GFP to Rat1p did not alter protein function.
Wild-type Rat1p fused to GFP was observed uniformly in the nucleus in nearly all cells (Fig. 6a through c) , regardless of cell cycle position. Control cells expressing Rat1p without GFP did not show any significant fluorescence (data not shown). Deletion of the putative NLS (NLS⌬) caused mislocalization of the protein throughout the cell (Fig. 6j) ; however, the mutant protein was not clearly excluded from the nucleus. Similar results were obtained with the KKK3AAA and ⌬492-529 mutations (data not shown). The K537E mutation, which alters a basic residue of the putative NLS consensus sequence, also resulted in mislocalization of the protein throughout the cell in addition to distinct fluorescence within the nucleus (Fig. 6g) . The localization of the K535N and H518Y mutant proteins was similar to that of K537E (data not shown). The weaker suppressing mutation, L520P, resulted in primarily a nuclear localization (Fig. 6d) . Similar localizations of wild-type and mutant Rat1p GFP fusion proteins were also observed in a diploid strain (data not shown).
These results indicate that the putative NLS is required for efficient nuclear localization of Rat1p. However, since the NLS⌬ mutant complemented the rat1-1 allele, either Rat1p can carry out its essential role in the cytoplasm in a capacity that Xrn1p cannot, or sufficient Rat1p still enters the nucleus for nuclear activity, suggesting that the protein may bear an additional NLS or can enter the nucleus by another mechanism. The first possibility was tested indirectly by targeting Xrn1p to the nucleus (see below).
Xrn1p targeted to the nucleus complements rat1-1. Previous work indicated that the Xrn1 protein can accept deletion of and protein fusions to the C terminus of the protein with little effect on the in vivo function of the protein (19, 25) . Consequently, a construct was made that encodes Xrn1p fused to GFP, including the SV40 large-T-antigen NLS, PKKKRKV, at the fusion junction. Xrn1p-NLS-GFP rescued the inviability of xrn1 ski2 mutants and the temperature sensitivity of rat1-1 (Table 4) . Similar results were obtained with a construct expressing intact Xrn1p bearing the SV40 large-T-antigen NLS but lacking GFP and from constructs expressed from a singlecopy vector (data not shown). Microscopic examination of cells containing this plasmid revealed bright nuclear fluorescence in most cells (Fig. 7) . That the XRN1-NLS fusion complemented b Scored by colony-sectoring assay in RDKY2053 or AJY354. Scores: Ϫ, no complementation; ϩ, weak complementation; ϩϩ, full complementation.
c Scored by complementation of temperature sensitivity of rat1-1. d Determined previously (17) .
an xrn1 ski2 double mutant suggests that sufficient Xrn1p remained in the cytoplasm to provide Xrn1p function. Since wild-type Xrn1p is cytoplasmic and does not complement rat1-1, even when XRN1 is present on a high-copy-number plasmid, these results show that the SV40 large-T-antigen NLS is sufficient to direct Xrn1p to the nucleus. More importantly, the presence of Xrn1p in the nucleus, but not in the cytoplasm, complemented the temperature sensitivity of rat1-1, demonstrating that Rat1p has an essential nuclear function that can be carried out by Xrn1p if Xrn1p is localized to the nucleus. To determine if the essential function of Rat1p or nucleartargeted Xrn1p is 5Ј exoribonuclease or another unidentified function of these proteins, an exonuclease-deficient mutant Xrn1p was targeted to the nucleus by the SV40 NLS and tagged with GFP. Replacement of glutamate 178 with glycine in Xrn1p abolishes detectable exonuclease activity (Fig. 8) , and the mutant protein is stable in vivo (data not shown). The localization of the exonuclease-deficient Xrn1p(E178G)-NLS-GFP was indistinguishable from that shown in Fig. 8 and did not rescue the temperature sensitivity of rat1-1 (data not shown). Thus, nuclear 5Ј exoribonuclease is essential.
RAT1 dominant alleles simultaneously complement xrn1⌬ and rat1-1 temperature sensitivity. By the way in which the dominant alleles of RAT1 were identified, it was expected that a single copy of a dominant RAT1 allele would simultaneously complement both xrn1 and rat1 defects. This was tested explicitly by introducing the dominant alleles on single-copy vectors into xrn1⌬ rat1-1 double mutants. Transformants were tested for growth at 26 and 37°C. xrn1 mutants display a slow-growth phenotype at 26 and 37°C which is rescued by a plasmid bearing wild-type XRN1 but not by a plasmid bearing wild-type RAT1 (Fig. 9) . Similarly, the temperature sensitivity of rat1-1 strains is rescued by a plasmid bearing RAT1 but not by one bearing XRN1. However, when the rat1-1 xrn1⌬ double mutant was transformed with a single-copy plasmid bearing either the L520P or K537E RAT1 mutation, the transformants grew as well as the wild type at 37°C. Thus, in these cells the two exoribonucleases, Xrn1p and Rat1p, normally found in the cytoplasm and nucleus, respectively, have been replaced by a single exoribonuclease generally distributed throughout the cell.
DISCUSSION
Deletion of XRN1, encoding the major cytoplasmic exoribonuclease responsible for mRNA degradation in yeast, is lethal in combination with null mutations of SKI2, encoding a putative RNA helicase. A screen for bypass suppressors of xrn1 ski2 inviability identified eighteen dominant mutants representing five mutations of RAT1, which encodes a 5Ј exonuclease that has considerable sequence homology with Xrn1p. Three of the mutations were T-to-C transitions in a repeated T sequence, and one mutation was a T-to-A transversion, typical of UVinduced lesions (31) . Although the screen was highly specific for RAT1, it remains possible that other, weaker suppressors exist which were not identified. Candidate xrn1-10 ts allele-specific suppressors were also identified and will be characterized separately.
The RAT1 alleles identified were dominant gain-of-function alleles. Because RAT1 is an essential gene, the alleles must retain RAT1 function and at the same time gain the ability to complement xrn1 or ski2 deficiency. The alleles were localized to a region of the RAT1 sequence encoding a potential bipartite NLS (11) . The putative NLS of RAT1 differs from the consensus NLS in that the 10-amino-acid spacer region between the basic clusters is extended to 15 residues. However, it has been reported that small insertions or deletions within the spacer region have little effect on nuclear targeting (11) . The different alleles of Rat1p displayed differing degrees of cytoplasmic mislocalization. The most extensive mislocalization, with no specific localization to the nucleus, was observed for mutations that altered more than one basic residue (⌬492-529, NLS⌬, and KKK3AAA). Mutations that affected only single basic residues of the consensus sequence resulted in cytoplasmic and nuclear localization, and the L520P mutation, which alters an amino acid of the spacer region and also is a weak suppressor, resulted in nearly wild-type nuclear localization. It is interesting that the H518Y mutation, which altered a residue other than a consensus residue, produces strong mislocalization. It is possible that this histidine actually serves as a basic residue in the NLS of Rat1p.
The finding that suppressors of xrn1 ski2 lethality were mutations in a putative NLS of Rat1p suggested that suppression was the result of mislocalization of Rat1p to the cytoplasm, where it could substitute for Xrn1p. This was confirmed by the use of GFP fusions to wild-type Rat1p and to Rat1 mutant proteins. Whereas wild-type Rat1-GFP was found exclusively in the nucleus, deletion of the putative NLS or mutations that altered conserved lysine residues led to distribution of the mutant proteins throughout the cell.
Since wild-type Rat1p is nuclear and apparently is targeted to the nucleus by a bipartite NLS, it was surprising that Rat1p lacking the potential NLS still complemented the rat1-1 mutant. Although by fluorescence microscopy it was not possible to conclude that deletion of the putative NLS prevented Rat1p entry into the nucleus, it could be inferred from the results of targeting Xrn1p to the nucleus that mutations within or deletion of the NLS of Rat1p do not entirely eliminate Rat1p from the nucleus. Thus, Rat1p may enter the nucleus by an alternate mechanism. It is possible that another sequence within Rat1p serves as a weak NLS. Examination of the protein sequences of the S. pombe and mouse homologs of Rat1p revealed potential NLSs in a position approximately 100 amino acids closer to the N terminus than the Rat1p NLS (Fig. 3b) . In the homologous position in Rat1p, a possible NLS with a spacer of 5 amino acids exists. It is possible that this sequence was the NLS of an ancestral protein and that the S. cerevisiae protein acquired a second NLS allowing divergence of the sequence used in the homologs. Alternatively, it is possible that Rat1p enters the nucleus by association with another protein or RNA. Indeed, during the purification of Rat1p, a 45-kDa protein was reported to copurify with Rat1p; however, the function of the 45-kDa protein is not known (40) . The previous finding that high-copy-number expression of RAT1 complemented an xrn1 mutation suggests that import of Rat1p into the nucleus becomes saturated by high-copy-number expression, allowing sufficient protein to remain in the cytoplasm. A previous attempt at Rat1p localization relied on high-copy-number expression of RAT1. Results of that analysis indicated Rat1p in the nucleus and cytoplasm (24) , consistent with the notion that high-copy-number expression of RAT1 leads to cytoplasmic mislocalization of the protein.
Rat1p and Xrn1p display similar in vitro biochemical activities. However, RAT1 is an essential gene whereas XRN1 is not. Since Rat1p function was maintained even when Rat1p was mislocalized throughout the cell, it was possible that the essential role of Rat1p could be carried out in the cytoplasm and that Xrn1p was incapable of carrying out this reaction. To test this idea, Xrn1p was directed to the nucleus by replacing the C-terminal 229 amino acids of Xrn1p with the SV40 large-Tantigen NLS fused to GFP. Such an XRN1-NLS-GFP1 construct complemented the temperature sensitivity of the rat1-1 allele and was localized to the nucleus. Thus, targeting Xrn1p to the nucleus allows Xrn1p to substitute for Rat1p, indicating that Rat1p carries out an essential function in the nucleus. This result strongly suggests that the mutations that result in the mislocalization of Rat1p complement the rat1-1 temperature sensitivity because sufficient Rat1p remains in the nucleus. More importantly, these results indicate that Rat1p and Xrn1p are functionally interchangeable proteins that normally reside and function in the nucleus and cytoplasm, respectively.
Possible roles of Rat1p. Although the data described here define Rat1p as a nuclear protein, they do not identify the substrates of Rat1p. From in vitro studies of Rat1p and Xrn1p, these enzymes are 5Ј exoribonucleases that require RNA substrates containing 5Ј PO 4 termini (40) . Numerous candidate substrates exist in the nucleus, including excised introns, rRNA intermediates, and tRNA processing products. The nucleases responsible for degradation of excised introns in the nucleus are largely unknown. However, deletion of the gene encoding the lariat debranching enzyme in yeast is not lethal but results in accumulation of excised introns (7) . This would suggest that if Rat1p plays a role in intron degradation, it is not an essential cellular function. rat1 mutants display increased levels of an extended form of 5.8S RNA (2), suggesting that one pathway for generating the 5Ј end of 5.8S RNA involves trimming by Rat1p (16) . However, other mutants that accumulate such extended 5.8S RNA are viable (16) , suggesting that this is not an essential function of Rat1p. It is also possible that Rat1p is required for the efficient removal of the portion of RNA polymerase II transcripts downstream of the poly(A) site. During transcription, the nascent transcript is cleaved at the site at which poly(A) is added. However, the portion of the transcript 3Ј to the cleavage site is a separate RNA species which could be eliminated by nucleases, perhaps in conjunction with an RNase H. In this regard, rat1-1 does not show synthetic lethality with a deletion of the RNase H domain of Rnh1 (unpublished data). Lastly, it is likely that Rat1p, like Xrn1p, will act on numerous substrates, complicating the identification of its essential role.
Implications for Xrn1p. The complementation of an xrn1 mutant by the mislocalization of Rat1p to the cytoplasm indicates that the pleiotropy of xrn1 mutants is due to lack of cytoplasmic mRNA degradation. Thus, the observed nuclear defects of xrn1 mutants (27, 32, 43) are likely the indirect consequences of altered gene regulation due to defective RNA turnover in the cytoplasm. The interchangeability of Rat1p and Xrn1p also suggests that specific protein-protein interactions of these proteins with other nuclear and cytoplasmic factors are not critical for their function. In this regard it has been suggested, based partially on the hypersensitivity of xrn1 mutants to the tubulin-destabilizing drug benomyl, that Xrn1p interacts with tubulin. Complementation of the benomyl hypersensitivity by cytoplasmic Rat1p could suggest that Rat1p is also capable of tubulin interaction. On the other hand, fluorescence of Rat1-GFP and indirect immunofluorescence of Xrn1p in S. cerevisiae do not show colocalization with tubulin (unpublished data).
The various RAT1 mutations identified here all restored cytoplasmic RNA turnover to similar degrees, even though localization studies indicated that the amount of Rat1p in the cytoplasm varied widely among the mutants. It is possible that Xrn1p and Rat1p are expressed in large excess over what is typically required in the cell and that significantly lower enzyme levels are sufficient for wild-type rates of most RNA degradation reactions. However, allele specificity was observed for suppression of benomyl hypersensitivity. This may reflect some other function of these proteins or the fact that unidentified RNA degradation or processing reactions are limiting in certain alleles, resulting indirectly in altered benomyl sensitivity.
Homologs of the XRN1 and RAT1 genes have been identified from mouse cells (3, 37) , and a RAT1 homolog has been identified from human cells (13a). The mouse Xrn1p homolog and the human Rat1p homolog display exonuclease activity (3, 13a) , and the mouse XRN1 and RAT1 homologs complement the respective mutants in yeast (3, 37) . Sequence analysis reveals that the Rat1p homologs contain putative bipartite NLSs, whereas the Xrn1p homologs do not. Thus, it is likely that within this family of eukaryotic exoribonucleases, the Xrn1 subfamily exists in the cytoplasm, where these proteins are responsible for mRNA turnover, whereas the proteins of the Rat1 subfamily are in the nucleus, where they function in some as yet unknown but essential role in RNA degradation.
